You're right Ivan, earnings for FY11 won't give a true picture of what CVA contributes, the real proof in the pudding will be in FY12 numbers. The company has increased the amount of capital by more than half so I'd want to see a more than 50% improvement in NPAT for FY12 from where they would have been in the absence of the acquisition. eg, if NPAT in the absence of CVA would have been $2.8m in FY12, I'd want to see NPAT in excess of $4.2m with CVA. That would show that they haven't diluted returns just for the sake of chasing growth.
- Forums
- ASX - By Stock
- something is happening
You're right Ivan, earnings for FY11 won't give a true picture...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add BGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.005(0.36%) |
Mkt cap ! $1.783B |
Open | High | Low | Value | Volume |
$1.38 | $1.41 | $1.35 | $20.45M | 14.85M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 262096 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.41 | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 56005 | 1.400 |
1 | 1422 | 1.395 |
5 | 23019 | 1.390 |
1 | 364 | 1.385 |
6 | 49621 | 1.380 |
Price($) | Vol. | No. |
---|---|---|
1.405 | 30000 | 1 |
1.410 | 20000 | 1 |
1.415 | 70730 | 2 |
1.420 | 182000 | 2 |
1.425 | 60000 | 4 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
BGL (ASX) Chart |